LYP3, a new bestatin derivative for aminopeptidase N inhibition

Medicinal Chemistry

Volumn 7, Issue 1, 2011, Pages 32-36

  Luan, Yepeng ^a   Ma, Chunhua ^a   Sui, Zhongguo ^b   Wang, Xuejian ^a   Feng, Jinhong ^a   Liu, Ning ^a   Jing, Fanbo ^b   Wang, Yan ^a   Li, Minyong ^a   Fang, Hao ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

A549; Aminopeptidase N; Bestatin; ES 2; MDA MB 231; Tumorigenesis

Indexed keywords

BESTATIN DERIVATIVE; ENZYME INHIBITOR; LYP 3; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANTIGENS, CD13; CELL LINE, TUMOR; HUMANS; LEUCINE; MATRIX METALLOPROTEINASE 2; MOLECULAR TARGETED THERAPY; NEOPLASMS; SOLUBILITY;

EID: 78751489488     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340611794072706     Document Type: Article

References (10)

1. Joong, S.S.; Jin, H.K.; Hyun, Y.C.; Young, N.Y.; Seung, H.K.; Hyun, J.P.; Bum, S.S.; Seung, H.C. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumiN. Chem. Biol., 2003, 10, 695-704.
2. Bhagwat, S.V.; Lahdenranta, J.; Giordano, R.; Arap, W.; Pasqualini, R.; Shapiro, L.H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Hemosta Thromb. Vasc. Biol., 2001, 97, 652-660.
3. Shii, K.; Usui, S.; Sugimur, Y.; Yamamoto, H.; Yoshikawa, K.; Hirano, K. Inhibition of Aminopeptidase N (AP-N) and Urokinase- Type Plasminogen Activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol. Pharm. Bull., 2001, 24, 226-230. (Pubitemid 32237158)
4. Saitoh, Y.; Koizumi, K.; Minami, T.; Sekine, K.; Sakurai, H.; Saiki, I.A. Derivative of Aminopeptidase Inhibitor (BE15) Has a Dual Inhibitory Effect of Invasion and Motility on Tumor and Endothelial Cells. Biol. Pharm. Bul., 2006, 29, 709-712.
5. Orning, L.; Krivi, G.; Bild, G.; Gierse, J.; Aykent, S.; Fitzpatrick, F.A. Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J. Biol. Chem., 1991, 266, 1375-1378.
6. Chung, M.C.; Lee, H.J.; Chun, H.K.; Lee, C.H.; Kim, S.I.; Kho, Y.H. Bestatin analogue from Streptomyces neyagawaensis SL-387. Biosci. Biotechnol. Biochem., 1996, 60(5), 898-900.
7. Tian, Z.Q.; Liu, Y.Q.; Zhang, D.; Wang, Z.; Steven, D.D.; Christopher, W.C.; Zhou, Y.Q.; Rastelli, G.; Daniel, V.S.; David, C.M. Synthesis and biological activities of novel 17- aminogeldanamycin derivatives. Bioorg. Med. Chem., 2004, 12, 5317-5329.
8. Mou, J.J.; Fang, H.; Jing, F.B.; Wang, Q.; Liu, Y.Z.; Zhu, H.W.; Shang, L.Q.; Wang, X.; Xu W.F. HDesign, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2009, 17(13), 4666-4673.
9. Baragi V.M.; Shaw B.J.; Renkiewicz R.R.; Kuipers P.J.; Welgus H.G.; Mathrubutham M.; Cohen J.R.; Rao S.K. A versatile assay for gelatinases using succinylated gelatin. Matrix. Biol., 2000, 19(3), 267-273.
10. Gao, J.J.; Gao, Z.H.; Zhao, C.R.; Yuan, Y.; Cui, S.X.; Zhang, X.F.; Cheng, Y.N.; Xu, W.F.; Tang, W.; Qu X.J. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin. Invest. New. Drugs., 2010, [Epub ahead of print].